Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trkA kinase inhibitors

Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trkA kinase inhibitors

US Patent 9809578 · Granted Nov 7, 2017

Estimated economic value: $14,586,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Spray-dried dispersions, formulations, and polymorphs of (S)-5-amino-3-(4-((5-fl2025
Spray-dried dispersions, formulations, and polymorphs of (s)-5-amino-3-(4-((5-fl2024
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors2024
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors2024
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors2024
RET kinase inhibitors2024
Compounds useful for inhibiting RET kinase2024
Fused heterocyclic compounds as RET kinase inhibitors2024
Fused heterocyclic compounds as RET kinase inhibitors2024
Protein tyrosine phosphatase inhibitors2024
Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the tre2024
Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the tre2024